As of 2025-11-03, the Relative Valuation of TG Therapeutics Inc (TGTX) is 5.69 USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.78 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -83.6%.
The range of the Relative Valuation is 2.99 - 8.59 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 22.5x | 19.9x |
| Forward P/E multiples | 18.8x - 29.0x | 23.9x |
| Fair Price | 2.99 - 8.59 | 5.69 |
| Upside | -91.4% - -75.3% | -83.6% |
| Date | P/E |
| 2025-10-31 | 91.28 |
| 2025-10-30 | 89.28 |
| 2025-10-29 | 88.65 |
| 2025-10-28 | 90.68 |
| 2025-10-27 | 88.42 |
| 2025-10-24 | 87.49 |
| 2025-10-23 | 87.89 |
| 2025-10-22 | 90.78 |
| 2025-10-21 | 92.43 |
| 2025-10-20 | 92.17 |
| 2025-10-17 | 90.99 |
| 2025-10-16 | 91.52 |
| 2025-10-15 | 91.99 |
| 2025-10-14 | 89.60 |
| 2025-10-13 | 89.81 |
| 2025-10-10 | 88.60 |
| 2025-10-09 | 91.78 |
| 2025-10-08 | 93.82 |
| 2025-10-07 | 95.79 |
| 2025-10-06 | 96.48 |
| 2025-10-03 | 96.33 |
| 2025-10-02 | 96.21 |
| 2025-10-01 | 95.95 |
| 2025-09-30 | 94.81 |
| 2025-09-29 | 96.66 |
| 2025-09-26 | 93.17 |
| 2025-09-25 | 90.91 |
| 2025-09-24 | 92.93 |
| 2025-09-23 | 93.35 |
| 2025-09-22 | 91.78 |
| 2025-09-19 | 84.95 |
| 2025-09-18 | 85.58 |
| 2025-09-17 | 84.09 |
| 2025-09-16 | 83.96 |
| 2025-09-15 | 83.33 |
| 2025-09-12 | 84.40 |
| 2025-09-11 | 85.19 |
| 2025-09-10 | 83.52 |
| 2025-09-09 | 83.98 |
| 2025-09-08 | 84.98 |
| 2025-09-05 | 84.53 |
| 2025-09-04 | 83.69 |
| 2025-09-03 | 83.22 |
| 2025-09-02 | 78.03 |
| 2025-08-29 | 76.98 |
| 2025-08-28 | 76.00 |
| 2025-08-27 | 74.98 |
| 2025-08-26 | 74.22 |
| 2025-08-25 | 74.88 |
| 2025-08-22 | 77.28 |